Vaxart Announces Closing of Registered Direct Offering of Common Stock
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 20, 2019--Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by table…
